tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Revenue

Compare
399 Followers

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 7.97M in the quarter ending Mar 31, 2025, with -90.79%. This bring the company's revenue in the last twelve months to 97.12M, Decreased 8.94%. In the fiscal year ending Dec 31, 2024, ARS Pharmaceuticals had annual revenue of 89.15M with 297063.33% growth.
Revenue (ttm)
97.12M
Revenue Growth
971120.00%
P/S Ratio
14.81
Revenue/Employee
$575,155
Employees
155
Market Cap
$1.32B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
89.15M89.12M+297,063.33%
Dec 31, 2023
30.00K-1.29M-97.72%
Dec 31, 2022
1.32M-4.19M-76.10%
Dec 31, 2021
5.51M-12.33M-69.13%
Dec 31, 2020
17.84M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis